- Sorry these notes are a bit delayed, this event got buried in the midst of the ASCO abstract release.
- Here are my brief notes from a 15 min 5/17/2011 SUPG webcast at noble financial conference:
- different speaker today - Michael V. McCullar, Ph.D., senior vice president, strategy and discovery operations...not too comfortable speaking and less effective...but read same slides as always
- Amuvatinib aka mp470 p2 trial will begin "shortly"
- Confirmed that Dacogen elderly AML US sNDA has been submitted by Eisai
- expect european submission later this year